Key Findings:  This study evaluating a rat model of epilepsy found that beta-caryophyllene plus pregabalin extended the time of onset of seizures, both myoclonic and tonic-clonic, and reduced the duration of tonic-clonic seizures and overall score. This suggests a potential synergistic approach to the treatment of drug-resistant seizure types.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Brazil
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2